MLM
Live chart
What they do
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally. It operates through East Group and West Group segments. The company offers crushed stone, sand, and gravel products; ready mixed concrete and asphalt.
For information only · Important disclosures
Grades vs sector
Momentum8th percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
Growth79th percentile in sectorB+
Percentile within its GICS sector across the S&P 1500.
Value18th percentile in sectorD
Percentile within its GICS sector across the S&P 1500.
Profitability69th percentile in sectorB
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Discounted cash flow
Starting cash flow is mid-cycle: 11.2% average margin × current revenue = 0.7B (last 12 months: 0.8B at a 12% margin). On trailing cash flow the base case would be $171.
Edit assumptions · recalculates instantly
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.08 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
pricier
pricier
pricier
pricier
pricier
pricier
Forward EPS $21.25 vs trailing $15.38 (+38% expected growth). Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Piotroski F-score 8/9 · last two fiscal years
Altman Z-score 3.3 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $6.2B | $1.1B | $978.0M |
| 2024 | $5.7B | $2.0B | $604.0M |
| 2023 | $5.9B | $1.2B | $878.0M |
| 2022 | $6.2B | $867.0M | $509.0M |
| 2021 | $5.4B | $702.5M | $714.6M |
| 2020 | $4.7B | $721.0M | $690.4M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -0.1%.
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | 4.64 | 5.00 | +7.6% |
| 2026-04-30 | 1.84 | 1.93 | +5.0% |
| 2026-02-11 | 4.98 | 4.62 | -7.2% |
| 2025-11-04 | 6.68 | 6.85 | +2.5% |
| 2025-08-07 | 5.26 | 5.43 | +3.2% |
| 2025-04-30 | 1.88 | 1.90 | +1.1% |
| 2025-02-12 | 4.56 | 4.81 | +5.5% |
| 2024-10-30 | 6.30 | 5.95 | -5.5% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.9B | +21.0% |
| 2026-03-31 | $1.4B | – |
| 2025-12-31 | $1.5B | – |
| 2025-09-30 | $1.8B | – |
| 2025-06-30 | $1.6B | – |
Analyst actions
PT $640
PT $650
PT $530
PT $662
PT $579
PT $625
Recent dividends
Insider trades
–
–
–
–
–
–
Stats refreshed 2026-10-21 18:01:57 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app
Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.
Beta 0.9 · Oct 21, 2026